Post by Fresenius Medical Care

Advancing transplant care starts with listening to patients. A new survey funded by the Fresenius Medical Care Foundation and published in the American Journal of Transplantation brings valuable insights from 10,000 transplant recipients worldwide highlighting both the effectiveness of today’s immunosuppressive therapies and the opportunities to further improve patient experience. The research reveals that 92% of patients reported experiencing at least one side effect, underscoring the importance of continued innovation and patient-centered care in transplantation. In our latest episode of Research in Brief, Benjamin Hippen, MD, FASN, FAST, joins John Gill, MD, PhD, and David Taber, PharmD, to explore what these findings mean for the future and how the transplant community can continue to move care forward. 👉 Read more about the study here: https://lnkd.in/eEpD7fWp #HealthcareInnovation #KidneyTransplant #TransplantCare #ResearchInBrief #ProudToBeFME

Video Content